Among adenocarcinoma lesions, MUC1 expression levels were increased in adenocarcinoma versus adenocarcinoma in situ (AIS), although not significantly (mean difference = 0.20, 95% CI, −0.055 to infinity, P = 0.094). This evidence concerns the gene MUC1 and adenocarcinoma.